Protective Effects of Probucol on the Cultured Human Umbilical Vein Endothelial Cell Injured by Lysophosphatidylcholine
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Aim To explore the protective effect of probucol on the human umbilical vein endothelial cell (hUVECs) injured by lysophosphatidylcholine. Methods Confluent hUVECs were incubated with Probucol for 24 h and consequently exposed to lysophosphatidylcholine. Lactate dihydrogenase (LDH), plasminogen activator inhibitor 1 (PAI 1)and tissue plasminogen activator(t PA) activity was measured in cell medium and lysate. Endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO)production were assessed by endothelial nitric oxide synthase and nitric oxide kits. Results Lysophosphatidylcholine enhanced markedly PAI 1, LDH activity and decreased nitric oxide bioavailability via the inhibited eNOS activity (p<0.01). These effects were attenuated by administration of different dose of probucol (10~50 mmol/L). Conclusions Lysophosphatidylcholine could injure hUVECs and inhibit eNOS and t PA activity directly. Probucol might play a protective role in hUVECs injured by lysophosphatidylcholine.

    Reference
    Related
    Cited by
Get Citation

TIAN Qing Yin, LIU Tong Tao, LI Bo Qin, PAN Qi Xing,,ZHU Qing. Protective Effects of Probucol on the Cultured Human Umbilical Vein Endothelial Cell Injured by Lysophosphatidylcholine[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2003,11(3):211-213.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 28,2002
  • Revised:April 29,2003
  • Adopted:
  • Online:
  • Published:
Article QR Code